FCFS

160

+1.52%↑

RPT.US

2.49

-1.19%↓

FCFS

160

+1.52%↑

RPT.US

2.49

-1.19%↓

FCFS

160

+1.52%↑

RPT.US

2.49

-1.19%↓

FCFS

160

+1.52%↑

RPT.US

2.49

-1.19%↓

FCFS

160

+1.52%↑

RPT.US

2.49

-1.19%↓

Search

Gimv NV

Fermé

SecteurFinance

44.95 -0.44

Résumé

Variation du prix de l'action

24h

Actuel

Min

44.85

Max

44.95

Chiffres clés

By Trading Economics

Ventes

114M

P/E

Moyenne du Secteur

6.145

31.165

BPA

2.43

Rendement du dividende

5.68

Employés

94

EBITDA

76M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.68%

3.89%

Prochains Résultats

20 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.7B

Ouverture précédente

45.39

Clôture précédente

44.95

Sentiment de l'Actualité

By Acuity

50%

50%

202 / 528 Classement par Finance

Gimv NV Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 nov. 2025, 17:45 UTC

Résultats
Principaux Mouvements du Marché

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

14 nov. 2025, 17:31 UTC

Résultats
Principaux Mouvements du Marché

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

15 nov. 2025, 18:03 UTC

Résultats

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- UPDATED -- WSJ

15 nov. 2025, 15:43 UTC

Résultats

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- WSJ

15 nov. 2025, 12:00 UTC

Résultats

Meta Opens Pop-Up Stores to Build Buzz for Its AI Glasses -- WSJ

15 nov. 2025, 09:20 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

15 nov. 2025, 09:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

15 nov. 2025, 00:08 UTC

Acquisitions, Fusions, Rachats

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

14 nov. 2025, 23:56 UTC

Acquisitions, Fusions, Rachats

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

14 nov. 2025, 23:02 UTC

Market Talk

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

14 nov. 2025, 22:35 UTC

Résultats
Acquisitions, Fusions, Rachats

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

14 nov. 2025, 22:32 UTC

Acquisitions, Fusions, Rachats

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

14 nov. 2025, 22:29 UTC

Résultats

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

14 nov. 2025, 22:00 UTC

Acquisitions, Fusions, Rachats

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

14 nov. 2025, 21:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

14 nov. 2025, 21:18 UTC

Acquisitions, Fusions, Rachats

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

14 nov. 2025, 20:27 UTC

Market Talk

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

14 nov. 2025, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

14 nov. 2025, 20:17 UTC

Acquisitions, Fusions, Rachats

Several State Attorneys General Oppose Railroad Merger -- WSJ

14 nov. 2025, 19:29 UTC

Market Talk
Résultats

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

14 nov. 2025, 18:44 UTC

Market Talk
Résultats

Disney's Growth Now Hinges More on ESPN -- Market Talk

14 nov. 2025, 18:27 UTC

Market Talk

Global Equities Roundup: Market Talk

14 nov. 2025, 18:27 UTC

Market Talk

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

14 nov. 2025, 18:20 UTC

Market Talk

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

14 nov. 2025, 17:20 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

14 nov. 2025, 17:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Health Care Roundup: Market Talk

14 nov. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14 nov. 2025, 16:51 UTC

Market Talk

Starbucks Gets Holiday Sales Lift -- Market Talk

14 nov. 2025, 16:48 UTC

Market Talk

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

14 nov. 2025, 16:38 UTC

Market Talk

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

Comparaison

Variation de prix

Gimv NV prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

202 / 528Classement par Finance

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat